Assyro AI

Orange Book product · Brand (NDA)

ROCURONIUM BROMIDE

ROCURONIUM BROMIDE

Brand (NDA)NDA 219108RX B BRAUN MEDICAL

At a glance

Oct 24, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 24, 2025

    8 mo ago

  2. Today

  3. Patent 11998605 expires

    Listed drug product patent expiration.

    Jul 22, 2039

    in 13 yr 3 mo

Pharmaceutical detail

Active ingredient

ROCURONIUM BROMIDE

Strength

50MG/5ML (10MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 219108

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11998605Jul 22, 2039in 13 yr 3 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.